CurrentCardio coverage · page 5 of 13
EP Europace
Latest from EP Europace
Europace
Europace
Comprehensive analysis of desmosomal protein remodelling identifies desmocollin-2 as potential biomarker for arrhythmogenic cardiomyopathy
Diagnostic or prognostic studyHeart failure
Europace
Europace
Europace
Europace
Europace
Left atrial appendage occlusion in patients with end-stage renal disease: an individual patient-level meta-analysis
Meta-analysisArrhythmias & EP
Europace
Ganglionated plexi ablation impact on AF mechanisms and outcomes in patients with low scar burden
Cohort studyArrhythmias & EP
Europace
Conduction system pacing versus biventricular pacing for cardiac resynchronization: the CSP-SYNC randomized single center study
Randomised controlled trialHeart failure
Europace
Europace
Europace
Europace
Impact of ventricular tachycardia ablation in the setting of electrical storm based on patient risk profile
Cohort studyArrhythmias & EP
Europace
Europace
Europace
Europace
EHRA perspective on the digital data revolution in arrhythmia management: insights from the association’s annual summit
Research articleArrhythmias & EP
Europace
Europace
Personalized pulmonary vein isolation guided by left atrial wall thickness for persistent atrial fibrillation ablation: the PeAF-by-LAWT randomized trial
Randomised controlled trialArrhythmias & EP
Europace
Europace
Europace
Venous thromboembolisms and stroke risk in patients with atrial fibrillation: a nationwide cohort study
Cohort studyArrhythmias & EP
Europace
Europace
Arrhythmia care in ESC member countries: the 2025 ESC-EHRA atlas on heart rhythm disorders
Cross-sectional studyArrhythmias & EP
Europace
Very high-power short-duration using 70W and a flexible tip ablation catheter for pulmonary vein isolation: the POWER PULSE randomized controlled trial
Randomised controlled trialArrhythmias & EP
Europace
Europace
Europace
Europace
Europace
Europace
Europace
Europace
Diagnostic yield in families to sudden cardiac death victims: a 10-year follow-up study
Cohort studyArrhythmias & EP
Europace
Assessment of activation delay in the right ventricular outflow tract as a potential complementary diagnostic tool for Brugada Syndrome
Diagnostic or prognostic studyArrhythmias & EP
Europace
Battery longevity of a helix-fixation dual-chamber leadless pacemaker: results from the AVEIR DR i2i Study
Secondary analysisArrhythmias & EP
Europace
Europace
Europace
Europace
Epicardial ablation in high-risk Brugada syndrome to prevent ventricular fibrillation: results from a randomized clinical trial
Randomised controlled trialArrhythmias & EP
Europace